MOS2-Carbon Nanodots as a New Electrochemiluminescence Platform for Breast Cancer Biomarker Detection

Gutiérrez-Gálvez, Laura; Vázquez Sulleiro, Manuel; Gutiérrez-Sánchez, Cristina; García-Nieto, Daniel; Luna, Mónica; Pérez, Emilio M.; García-Mendiola, Tania; Lorenzo Abad, Encarnación

Use this link to cite:

http://hdl.handle.net/2183/42027

MOS2-Carbon Nanodots as a New Electrochemiluminescence Platform for Breast Cancer Biomarker Detection

Files

VázquezSulleiro_Manuel_2023_MOS2-Carbon_Nanodots_as_a_New-Electrochemiluminescence.pdf (3.32 MB)

Identifiers

URI: http://hdl.handle.net/2183/42027

Publication date

2023-03-05

Authors

Gutiérrez-Gálvez, Laura

Vázquez Sulleiro, Manuel

Gutiérrez-Sánchez, Cristina

García-Nieto, Daniel

Luna, Mónica

Pérez, Emilio M.

García-Mendiola, Tania

Lorenzo Abad, Encarnación

Bibliographic citation

Gutiérrez-Gálvez, L.; Sulleiro, M.V.; Gutiérrez-Sánchez, C.; García-Nieto, D.; Luna, M.; Pérez, E.M.; García-Mendiola, T.; Lorenzo, E. MoS2-Carbon Nanodots as a New Electrochemiluminescence Platform for Breast Cancer Biomarker Detection. Biosensors 2023, 13, 348.

Abstract

[Abstract] In this work, we present the combination of two different types of nanomaterials, 2D molybdenum disulfide nanosheets (MoS2-NS) and zero-dimensional carbon nanodots (CDs), for the development of a new electrochemiluminescence (ECL) platform for the early detection and quantification of the biomarker human epidermal growth factor receptor 2 (HER2), whose overexpression is associated with breast cancer. MoS2-NS are used as an immobilization platform for the thiolated aptamer, which can recognize the HER2 epitope peptide with high affinity, and CDs act as coreactants of the anodic oxidation of the luminophore [Ru(bpy)3]2+. The HER2 biomarker is detected by changes in the ECL signal of the [Ru(bpy)3]2+/CD system, with a low detection limit of 1.84 fg/mL and a wide linear range. The proposed method has been successfully applied to detect the HER2 biomarker in human serum samples.